Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Finished Goods: 2024

Historic Finished Goods for Whitehawk Therapeutics (WHWK) over the last 1 years, with Dec 2024 value amounting to $1.8 million.

  • Whitehawk Therapeutics' Finished Goods was N/A to $1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2024, which is N/A change from last year.
  • Whitehawk Therapeutics' Finished Goods amounted to $1.8 million in FY2024.
  • In the past 5 years, Whitehawk Therapeutics' Finished Goods registered a high of $1.8 million during FY2024, and its lowest value of $1.8 million during FY2024.
  • For the 1-year period, Whitehawk Therapeutics' Finished Goods averaged around $1.8 million, with its median value being $1.8 million (2024).